Rezension:

I've been made redundant rx staxyn In ensuring that data de-identification measures were sufficient to protect patients, the EMA would need to consider “not only the clinical data themselves, but also all other public information that could be combined with study data to deduce subject identities, including discharge data, data in public study databases, claims data, US and EMA clinical trials databases, and even social media”, it says. 

Bewertung: